Clinical Trial Update: Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rosuvastatin and pravastatin in HIV patients on boosted protease inhibitors to evaluate lipid-lowering efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• Pravastatin (pravastatin)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hyperlipidemia, HIV Infections | Phase 4 | Status: COMPLETED